FDA Drug Recalls

Eugia US LLC puts a voluntary recall on Acyclovir Sodium Injection 500 mg per lot number AC22006 due to the presence of particulates. This recall is being made with the knowledge of the U.S. Food and Drug Administration (FDA). The recall is in response to complaints of the presence of dark red, brown, and/or black […]

Salon Technologies International. Inc. has issued a nationwide voluntary recall of Antica Ocean Citron Hand Sanitizer (Alcohol) Gel 65% due to the presence of benzene. This hand sanitizer does not meet the safety standards set by the U.S. Food and Drug Administration (FDA) for Benzene in cosmetics, which is 0.1%. Salon Technologies International. Inc. voluntarily

Family Dollar Stores, Inc. is voluntarily recalling certain products regulated by the U.S. Food and Drug Administration (FDA) because they were stored outside of temperature requirements in some of its distribution centers. The affected products were stored and shipped to different stores between May 1, 2022, through June 21, 2022. The stores are in AZ,

On July 21, 2022, Ultra Supplement LLC voluntarily recalled lot number DAP272109 of Sustango capsules packaged in ten-count blisters released for distribution to consumers. The recalled lot number had an expiry date of 4/01/2026. The manufacturer was notified by Amazon that preliminary laboratory analysis established that the capsules contained traces of undeclared tadalafil, an ingredient

On July 5, 2022, Mylan Pharmaceuticals Inc, a Viatris Company, issued a voluntary recall of one batch of Insulin Glargine Injection, 100 units/ml, 3mL prefilled pens, which were packaged in cartons of five injection pens to the consumer level. However, the recalled product is not the branded Semglee pen but the unbranded Insulin Glargine-yfgn pens.

MKS Enterprise LLC has issued a voluntary recall of Dose Vital VIP Honey over fears of undeclared active pharmaceutical ingredient Tadalafil. The recall was issued on July 18, 2022, and the official recall announcement was published by the Food and Drug Administration on July 19, 2022. Tadalafil is a phosphodiesterase type-5 inhibitor commonly used to